Balyasny Asset Management LLC Horizon Therapeutics Public LTD CO Put Options Transaction History

Balyasny Asset Management LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $1.61 Million - $1.89 Million	-16,300 Reduced 1.17%	1,374,100 $159 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $15.8 Million - $18.4 Million	163,800 Added 13.35%	1,390,400 $143 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $26.3 Million - $27.8 Million	-245,200 Reduced 16.66%	1,226,600 $134 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $91.6 Million - $167 Million	1,467,800 Added 36695.0%	1,471,800 $167 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $235,680 - $338,680	4,000 New	4,000 $248,000

Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $4.56 Million - $5.7 Million	200,000 New	200,000 $4.75 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.